Stock Earnings

Question 1

What are Abbott Laboratories's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Abbott Laboratories has a total asset of $86,713, Net profit of $6,524

Question 2

What are the key financial ratios for ABT?

Accepted Answer

Abbott Laboratories's Current ratio is 2.5, has a Net margin is 14.71, sales per share of $25.35.

Question 3

How is Abbott Laboratories's revenue broken down by segment or geography?

Accepted Answer

Abbott Laboratories largest revenue segment is Established Pharmaceutical Products, at a revenue of 5,536,000,000 in the most earnings release.For geography, United States is the primary market for Abbott Laboratories, at a revenue of 17,126,000,000.

Question 4

Is Abbott Laboratories profitable?

Accepted Answer

yes, according to the latest financial statements, Abbott Laboratories has a net profit of $6,524

Question 5

Does Abbott Laboratories have any liabilities?

Accepted Answer

yes, Abbott Laboratories has liability of 34,583

Question 6

How many outstanding shares for Abbott Laboratories?

Accepted Answer

Abbott Laboratories has a total outstanding shares of 1,736.59

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	45,134	44,328	41,950	40,109	43,653	43,075
Revenue Growth (YoY)	7%	6%	5%	-8%	1%	24%
Cost of Revenue	19,635	19,210	18,644	17,919	19,083	18,490
Gross Profit	25,499	25,118	23,306	22,190	24,570	24,585
Selling, General & Admin	12,434	12,220	11,651	10,883	11,109	11,217
Research & Development	2,929	2,889	2,784	2,619	2,741	2,733
Operating Expenses	17,047	16,791	16,313	15,468	15,863	15,997
Other Non Operating Income (Expenses)	573	548	558	518	366	277
Pretax Income	8,137	8,466	7,013	6,664	8,306	8,211
Income Tax Expense	1,861	1,942	-6,389	941	1,373	1,140
Net Income	6,276	6,524	13,402	5,723	6,933	7,071
Net Income Growth	-54%	-51%	134%	-17%	-2%	56.99%
Shares Outstanding (Diluted)	1,747	1,748	1,748	1,749	1,764	1,789
Shares Change (YoY)	0%	0%	0%	-1%	-1%	0%
EPS (Diluted)	3.6	3.73	7.67	3.27	3.93	3.95
EPS Growth	-53%	-51%	135%	-17%	-1%	56.99%
Free Cash Flow	7,378	7,395	6,351	5,059	7,804	8,648
Free Cash Flow Per Share	4.22	4.23	3.63	2.89	4.42	4.83
Gross Margin	56.49%	56.66%	55.55%	55.32%	56.28%	57.07%
Operating Margin	18.72%	18.78%	16.66%	16.75%	19.94%	19.93%
Profit Margin	13.9%	14.71%	31.94%	14.26%	15.88%	16.41%
Free Cash Flow Margin	16.34%	16.68%	15.13%	12.61%	17.87%	20.07%
EBITDA	11,615	11,443	10,211	9,965	11,974	12,126
EBITDA Margin	25.73%	25.81%	24.34%	24.84%	27.42%	28.15%
D&A For EBITDA	3,163	3,116	3,218	3,243	3,267	3,538
EBIT	8,452	8,327	6,993	6,722	8,707	8,588
EBIT Margin	18.72%	18.78%	16.66%	16.75%	19.94%	19.93%
Effective Tax Rate	22.87%	22.93%	-91.1%	14.12%	16.53%	13.88%

Abbott Laboratories (ABT) Price

ABT Stock Price Chart

ABT Income

Follow-Up Questions